Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Nat Genet ; 54(2): 170-179, 2022 02.
Article in English | MEDLINE | ID: mdl-35115686

ABSTRACT

Inherited noncoding genetic variants confer significant disease susceptibility to childhood acute lymphoblastic leukemia (ALL) but the molecular processes linking germline polymorphisms with somatic lesions in this cancer are poorly understood. Through targeted sequencing in 5,008 patients, we identified a key regulatory germline variant in GATA3 associated with Philadelphia chromosome-like ALL (Ph-like ALL). Using CRISPR-Cas9 editing and samples from patients with Ph-like ALL, we showed that this variant activated a strong enhancer that upregulated GATA3 transcription. This, in turn, reshaped global chromatin accessibility and three-dimensional genome organization, including regions proximal to the ALL oncogene CRLF2. Finally, we showed that GATA3 directly regulated CRLF2 and potentiated the JAK-STAT oncogenic effects during leukemogenesis. Taken together, we provide evidence for a distinct mechanism by which a germline noncoding variant contributes to oncogene activation, epigenetic regulation and three-dimensional genome reprogramming.


Subject(s)
Chromatin/chemistry , GATA3 Transcription Factor/genetics , Genetic Predisposition to Disease , Polymorphism, Single Nucleotide , Precursor Cell Lymphoblastic Leukemia-Lymphoma/genetics , Child , Chromatin/metabolism , Enhancer Elements, Genetic , Female , GATA3 Transcription Factor/metabolism , Genome, Human , Humans , Janus Kinases/metabolism , Male , Oncogenes , Philadelphia Chromosome , Protein Binding , Receptors, Cytokine/genetics , Receptors, Cytokine/metabolism , STAT Transcription Factors/metabolism , Signal Transduction , Up-Regulation
SELECTION OF CITATIONS
SEARCH DETAIL
...